Celularity Inc. (Nasdaq: CELU) (the“Company”), a regenerative medicine company developing and commercializing placental-derived technologies, today announced that it has received a formal notice from ...
Violets' cyclotides could revolutionize glioblastoma treatment by boosting chemotherapy efficacy, now advancing to mouse ...
McMaster University researchers have discovered a previously unknown cell-protecting function of a protein, which could open new avenues for treating age-related diseases and lead to healthier aging ...